Loading
Everything OnCo dates to 1946: 12 entries, 4 companies founded, 4 landmarks, 2 technologies and 1 journal founded. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.
12 dated entries in OnCo fall in 1946: 4 companies founded, 4 landmarks, 2 technologies, 1 journal founded and 1 regulatory event.
Of those, 12 to the year only. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.
Everything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.
The regulatory events on treatment records: designations, filings, decisions, label changes and withdrawals, most of them carrying a full date.
First therapeutic use in thyroid cancer (Seidlin); formal approval followed
The history entries editors wrote on cancer records: the dated turning points of each disease.
Thyroid cancer. Seidlin, Marinelli, and Oshry: the first theranostic.
Papillary thyroid cancer
Follicular thyroid cancer
Thyroid cancer
The since year on technology records: first use in humans or first approval, as the record states it.
First use in humans or first approval, as the technology record states it.
First use in humans or first approval, as the technology record states it.
The founded year on company records.
Aachen
Yongin
Matsumoto
Madrid
The founded year on journal records.
American Society of Hematology